Silkworm pupa powder for Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests if a powder made from silkworm pupae can help improve memory and thinking in people with Alzheimer's disease. It is for people with mild to severe Alzheimer's who have clear signs of the disease in their blood or brain scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Alzheimer's disease, and your memory and thinking problems are mild to severe.
- You have had a blood test or brain scan that shows signs of Alzheimer's (amyloid and tau proteins).
- You are 50 to 90 years old and have at least a primary school education.
- You have a family member or friend who can help you during the study.
- You are not taking antibiotics for more than 10 days in the last 3 months, and you do not expect to need long-term antibiotics during the study.
- You do not have another type of dementia or serious health problems like uncontrolled heart, lung, or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether silkworm pupa powder can help slow memory loss and thinking problems in people with mild-to-moderate Alzheimer's disease. Researchers will check if it works by measuring changes in memory, thinking ability, and brain markers over time.
This trial tests whether a dietary supplement made from silkworm pupa powder can improve nutrition in people with Alzheimer's disease. It looks at weight, nutrition risk, and daily living skills over time.
This trial tests whether a supplement made from silkworm pupa powder can improve nutrition in people with Alzheimer's disease. It aims to see if this natural product can help with weight and overall health.
This study tests whether tiny particles called exosomes derived from neural stem cells can help slow memory loss and thinking problems in people with Alzheimer's disease that started before age 65. The treatment is given through the nose and aims to reduce harmful proteins in the brain.
This trial tests whether silkworm pupa powder can improve nutrition and reduce frailty in people with motor neuron disease (like ALS). It looks for volunteers who are frail, have a confirmed diagnosis, and are willing to provide blood, stool, and urine samples.
This trial tests whether acupuncture can improve symptoms in people with Alzheimer’s disease. You may qualify if you have memory and thinking changes consistent with Alzheimer’s and meet imaging and brain-scan score requirements.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.